An increasing trend was observed with the number of comorbidities, where compared to no comorbidities (US$10,522.72), 2 or 3 comorbidities ( n = 1301) elevated the average admission cost by 16%, and >3 comorbidities ( n = 452) increased it by 19%.
← all excerpts
COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors.
1
—
—